Navigation Links
American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast
Date:8/31/2008

WASHINGTON, Sept. 1 /PRNewswire-USNewswire/ -- There has been recent concern that suicide may be a complication of montelukast (Singulair) therapy. Montelukast is a Food and Drug Administration (FDA) approved oral drug that has been prescribed for more than a decade for the treatment of asthma and seasonal allergy symptoms. An independent study sponsored by the American Lung Association has found no evidence of depression or suicide linked to montelukast.

American Lung Association researchers Janet Holbrook, PhD, MPH and Raida Harik-Khan, PhD have re-analyzed data from patients who had participated in past clinical trials involving montelukast conducted by the Association's Asthma Clinical Research Centers (ACRC) Network to identify any signals that might suggest a link between montelukast and its effect on emotional well- being. They report their findings in an upcoming issue of the Journal of Allergy and Clinical Immunology.

"Discovering adverse effects of a drug after it is on the market can be very difficult, because the data are usually gathered from single events reported by doctors, which makes it is challenging to differentiate actual side effects from events unrelated to the drug," said Norman Edelman, MD American Lung Association Chief Medical Officer. "The value of this 'look back' study is that the investigators were able to compare a large group of patients given montelukast with those given a placebo making a firm scientific conclusion possible."

Holbrook and Harik-Khan reviewed quality of life and emotional well being data collected from patients in three American Lung Association ACRC Network clinical trials that had used montelukast as one of their treatments. Of the 1,352 patients who participated in the double-blind, controlled studies, 569 of these patients had been randomly assigned to take montelukast. The researchers analyzed these patients' data and found no evidence of any deterioration of emotional well being in
'/>"/>

SOURCE American Lung Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
4. Aspirin Named 8th World Wonder by Majority of Americans
5. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
7. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
8. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
9. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)...  Flagship Ventures, a leading venture capital and ... today announced the appointment of Stephane ... this role, Mr. Bancel will provide strategic counsel ... addition to working closely with companies in the ... and Chief Executive Officer of Moderna Therapeutics, a ...
(Date:5/22/2013)...  Grifols, a global healthcare company based in ... study demonstrating that a higher dose of PROLASTIN © ... the alpha 1 protein in patients with alpha ... within the normal range for healthy individuals. AAT deficiency ... of the alpha 1 proteinase inhibitor (A1PI) protein ...
(Date:5/22/2013)... 2013  Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical ... unmet medical needs, today announced the appointment of ... its Board of Directors. Dr. Almenoff has extensive experience ... stage drug development. "We are delighted ... Irach Taraporewala, CEO of Ohr Pharmaceutical. "She offers tremendous ...
Breaking Medicine Technology:Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3
... N.Y., Sept. 15 Sono-Tek Corporation (OTC Bulletin Board: ... at the symposium of advanced coating technologies, whose aim ... on coating science and technology.  The symposium was attended ... medical and energy projects and by academia from around ...
... U.S. Food and Drug Administration is notifying health care ... tablets and solution used by children and adolescents receiving ... to prevent drug overdosing of children with low body ... creatinine. The revised dosing instructions now appear in the ...
Cached Medicine Technology:Sono-Tek Presents at the 15th International Coating Science and Technology Symposium (ISCST, St. Paul, MN) 2FDA Issues New Dosing Guide for Children Using Valcyte 2
(Date:5/22/2013)... Texas (PRWEB) May 22, 2013 Beginning ... On” in the Conrad Foundation’s Spirit of Innovation ... and technical plan competition, free and open to students ... , The Spirit of Innovation Challenge celebrates the life ... to walk on the Moon. The program challenges teens ...
(Date:5/22/2013)... Rye Brook, New York (PRWEB) May 22, 2013 ... clinic that specializes in combining treatments for optimal results, ... thicken thin skin on the neck. The practice ... and seen dramatic results. , “Basically, this approach is ... neck lift,” says Westchester dermatologist Dr. Michelle ...
(Date:5/22/2013)... JoVE will publish details of a ... relation to a patients age. The method is demonstrated by ... Einstein College of Medicine. Dr. Atzmon hopes that the dissemination ... genetic thermometer to assess a patients health in relation to ... publication will feature a technique that measures telomere length. ...
(Date:5/22/2013)... GA (PRWEB) May 22, 2013 ... agency, JD Media Surge, LLC, E-Dentists.com has launched ... The blog will feature numerous topics of interest ... treatment options and dental health. , http://www.E-Dentists.com/Blog/ ... of dental Internet marketing. In addition to addressing ...
(Date:5/22/2013)... May 2013, Paris, France: Results from a ... today question whether bivalirudin is superior to ... showing similar 30-day mortality in patients with ... undergoing percutaneous coronary intervention (PCI)., European and ... as an alternative to unfractionated heparin plus ...
Breaking Medicine News(10 mins):Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2Health News:How healthy are you for your age? 2Health News:Dental SEO Blog Launched by E-Dentists.com in Partnership with JD Media Surge, LLC 2Health News:Registry questions superiority of bivalirudin over heparin 2
... the perfect night,s sleepDALLAS, April 7 ... a free-standing, patent pending kiosk that contains all of the ... product breaks the mold for the industry standards of soft, ... an individual,s sleep preference of side, back or stomach sleeper. ...
... strategic analysis of technologies. , ... Atlanta, GA ... global leader in legal consulting, technology and outsourcing, today announced it ... vendor of software tools that enable rapid comprehension and decision making ...
... of anti-aging injections continue, as do false claims and risk ... ... Physicians Coalition for Injectable Safety , There is no debating ... themselves, particularly in appearance enhancing treatments that restore youth and erase ...
... traits of wisdom appear to follow a universal path ... -- Wisdom appears to be more than a subjective ... circuits and pathways, suggest U.S. researchers who compiled the ... this type of research could potentially lead to interventions ...
... therapy, household changes added 3.5 years on average, study ... home-based program for seniors that includes occupational and physical ... help people live longer, new research found. , In ... 3.5 years of lifespan compared to those who didn,t, ...
... Community Hospice of Northeast Florida , in collaboration ... across the country to complete their advance healthcare directives ... designation of April 16, 2009 ... recent gains in public awareness of the need for ...
Cached Medicine News:Health News:Now Available Online, The Pillow Bar is the Right Mix of Luxury and Necessity 2Health News:UnitedLex Announces Strategic Alliance with Oval Ideas to Enable Superior Patent Analytics 2Health News:Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions 2Health News:Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions 3Health News:Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions 4Health News:Pathway to Wisdom May Be Found in Brain Circuitry 2Health News:Home-Based Program Extends Seniors' Lives 2Health News:Home-Based Program Extends Seniors' Lives 3Health News:Community Hospice Supports National Healthcare Decisions Day 2Health News:Community Hospice Supports National Healthcare Decisions Day 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: